...
首页> 外文期刊>Journal of Thrombosis and Thrombolysis >Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus
【24h】

Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus

机译:D-二聚体与2型糖尿病患者微量白蛋白尿的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Background Microalbuminuria has been reported to be related to incidence of cardiovascular complications in diabetes. No consistent findings have been obtained on the relationships of microalbuminuria with blood coagulation and fibrinolysis. The purpose of this study was to determine whether microalbuminuria is associated with blood markers reflecting coagulation and fibrinolysis activities in patients with type 2 diabetes. Methods The relationships of albumin excretion rate (AER) with atherosclerosis-related variables, including blood coagulation and fibrinolysis markers, were investigated in patients with type 2 diabetes who showed normoalbuminuria (AER: less than 20 μg/min) and microalbuminuria (AER: 20 μg/min or higher and less than 200 μg/min). Results AER was significantly correlated with body mass index (BMI), maximum intima-media thickness of common carotid arteries, blood HDL cholesterol, uric acid, creatinine and D-dimer. On the other hand, AER showed no significant correlation with blood platelets, fibrinogen, thrombin–antithrombin III complex, plasmin–α2 plasmin inhibitor complex and plasminogen activator inhibitor-1. In multiple regression analysis, using age, sex, BMI, pulse pressure, hemoglobin A1c, HDL cholesterol, uric acid, creatinine, D-dimer and history of anti-thrombotic therapy as explanatory variables, only D-dimer showed a significant correlation with AER. The mean level of log-converted D-dimer after adjustment for age and sex was significantly higher in subjects with microalbuminuria than in those with normoalbuminuria. Conclusions D-dimer is associated with microalbuminuria in patients with diabetes and this suggests that glomerular dysfunction is in part mediated by hypercoagulability.
机译:背景技术据报道,微量白蛋白尿与糖尿病中心血管并发症的发生有关。在微量白蛋白尿与血液凝固和纤维蛋白溶解的关系方面尚未获得一致的发现。这项研究的目的是确定微量白蛋白尿是否与反映2型糖尿病患者凝血和纤溶活性的血液标志物相关。方法在患有白蛋白尿(AER:小于20μg/ min)和微量白蛋白尿(AER:20)的2型糖尿病患者中,研究白蛋白排泄率(AER)与动脉粥样硬化相关变量(包括凝血和纤溶指标)的关系。 μg/ min或更高且小于200μg/ min)。结果AER与体重指数(BMI),颈总动脉最大内膜中层厚度,血液HDL胆固醇,尿酸,肌酐和D-二聚体显着相关。另一方面,AER与血小板,纤维蛋白原,凝血酶-抗凝血酶III复合物,纤溶酶-α2纤溶酶抑制剂复合物和纤溶酶原激活物抑制剂-1没有显着相关性。在多元回归分析中,以年龄,性别,BMI,脉压,血红蛋白A1c,HDL胆固醇,尿酸,肌酐,D-二聚体和抗血栓治疗史为解释变量,只有D-二聚体显示与AER显着相关。对微白蛋白尿患者进行对年龄和性别的调整后,对数转化的D-二聚体的平均水平显着高于对白蛋白尿患者。结论D-二聚体与糖尿病患者的微量白蛋白尿有关,这表明肾小球功能障碍部分是由高凝性介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号